Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
1.
Neurol Sci ; 44(12): 4233-4245, 2023 Dec.
Article in English | MEDLINE | ID: mdl-37542547

ABSTRACT

OBJECTIVE: The scope of this paper is to review the subtypes of transient ischemic attack (TIA) and minor stroke (mS) in which a surgical treatment is needed, discussing the importance and the timing of a multidisciplinary approach, in order to achieve an optimized management and prevent major strokes or other critical complications. MATERIALS AND METHODS: The keywords "transient ischemic attack," "minor stroke," "surgical treatment," "vascular surgery," "heart surgery," "neurosurgery," and "multidisciplinary" were searched using MEDLINE, EMBASE, and Scopus. Relevant search results were discussed by the authors for references inclusion. RESULTS: Notwithstanding that best medical therapy is usually the first choice for the most part of cases, there are specific but recurrent etiologies that must be properly recognized because of a potential surgical approach, even in urgency. In fact, symptomatic carotid stenosis, or particular cases of hemodynamic cerebrovascular events, should be promptly referred to vascular surgeon, since increasing evidences highlighted a benefit from an early artery revascularization. In addition, beyond arrhythmic causes, cardioembolic events due to bacterial endocarditis and atrial myxoma should be quickly diagnosed, possibly in emergency department, because they are a presumptive urgency for heart surgery. In addition to the above-mentioned conditions, in patients suffering from vertebrobasilar TIA or mS, clinicians should keep in mind the Bow Hunter disease, because surgical artery decompression can represent the only suitable treatment in selected cases. CONCLUSIONS: TIA and mS require a multidisciplinary in order to discuss therapeutic options, comparing risks and benefits and determining the best timing for an optimized management.


Subject(s)
Carotid Stenosis , Ischemic Attack, Transient , Stroke , Surgeons , Humans , Ischemic Attack, Transient/complications , Ischemic Attack, Transient/therapy , Stroke/etiology , Stroke/therapy , Stroke/diagnosis , Carotid Stenosis/complications , Secondary Prevention , Risk Factors
2.
Eur J Vasc Endovasc Surg ; 53(6): 793-801, 2017 Jun.
Article in English | MEDLINE | ID: mdl-28341530

ABSTRACT

OBJECTIVES: To analyse the results and review the literature about thoracic aortic endovascular repair (TEVAR) for type B acute aortic dissection (TBAAD) complicated by descending thoracic aortic aneurysm (DTA) in the hyperacute or acute phases. METHODS: This was a multicentre, observational descriptive study. Inclusion criteria were TBAAD with a DTA of ≥50 mm, TBAAD on an already known aneurysmal descending thoracic aorta, and TBAAD presenting with an enlarged aorta with a total diameter <50 mm, but with >50% diameter increase compared with a previous computed tomography angiography (CTA) showing a non-dissected aorta with normal sizing. Primary endpoints were early and long-term survival, freedom from TEVAR and aortic related mortality (ARM), and freedom from re-intervention. RESULTS: Twenty-two patients were included in the analysis. The mean aortic diameter was 66 ± 26 mm (range 42-130; IQR 51-64). The in hospital TEVAR related mortality was 14% (n = 3). The mean radiological follow-up was 56 ± 45 months (range 6-149; IQR 12-82), and the follow-up index 0.97 ± 0.1. All surviving patients were available for follow-up. During follow-up the cumulative mortality was 26% (n = 5) and TEVAR related mortality was 5% (n = 1). Overall the estimate of survival was 82% (95%CI: 61.5-93) at 1 year, and 64% at 5 years. Ongoing primary clinical success was 79% (re-intervention n = 4). Freedom from aortic related mortality was 86% (95%CI: 66-95) at 1 and 5 year, while freedom from re-intervention was 95% (95%CI: 75.5-95) at 1 year, and 77% (95%CI: 50-92) at 5 years. CONCLUSIONS: In our experience, DTA is a frequent complication from the very beginning of the clinical onset of TBAAD. In this high-risk cohort, TEVAR showed satisfactory results, better than those predicted by the risk score for open repair, with favourable stability of the aortic diameter and no aortic related adverse events during follow-up.


Subject(s)
Aortic Aneurysm, Thoracic/surgery , Aortic Dissection/surgery , Blood Vessel Prosthesis Implantation , Endovascular Procedures , Acute Disease , Aged , Aortic Dissection/diagnostic imaging , Aortic Dissection/mortality , Aortic Aneurysm, Thoracic/diagnostic imaging , Aortic Aneurysm, Thoracic/mortality , Aortography/methods , Blood Vessel Prosthesis Implantation/adverse effects , Blood Vessel Prosthesis Implantation/mortality , Computed Tomography Angiography , Disease-Free Survival , Endovascular Procedures/adverse effects , Endovascular Procedures/mortality , Female , Humans , Italy , Kaplan-Meier Estimate , Male , Middle Aged , Retrospective Studies , Risk Factors , Time Factors , Treatment Outcome
3.
J Cardiovasc Surg (Torino) ; 53(2): 187-94, 2012 Apr.
Article in English | MEDLINE | ID: mdl-22456641

ABSTRACT

AIM: The aim of this study was to evaluate early and follow-up results of below-knee bypasses performed with a bioactive heparin-treated ePTFE graft in patients with peripheral arterial obstructive disease (PAOD) in a multicentric retrospective registry involving seven Italian vascular centers and to compare them with those obtained in patients operated on with autologous saphenous vein (ASV) in the same centres in the same period of time. METHODS: Over a nine-year period, ending in 2010, a heparin bonded prosthetic graft (Propaten Gore-Tex, W.L. Gore & Associates Inc, Flagstaff, AZ, USA) was implanted in 556 patients undergoing below-knee revascularization for PAOD (HePTFE group). In the same period of time 394 below-knee bypasses with ipsilateral ASV were performed (ASV group). Data concerning these interventions were retrospectively collected in a multicenter registry with a dedicated database. Early (<30 days) results were analyzed in terms of graft patency, major amputation rates and mortality. Follow-up results were analyzed in terms of primary and secondary graft patency, limb salvage and survival. RESULTS: Among patients of HePTFE group, 413 had critical limb ischemia (74%); the corresponding figure for ASV group was 84% (332 interventions, P<0.001). Eighty-nine patients in HePTFE group (16%) and 207 patients in ASV group (52.5%; P<0.001) had distal tibial anastomosis. Patients in HePTFE group had more frequently adjunctive procedures performed at distal anastomotic sites in order to improve run-off status. Thirty-day death rate was 1.9% in HePTFE group and 0.5% in ASV group (P=0.08). The rates of perioperative thromboses and amputations were 6% and 3.5% in HePTFE group, and 5% and 1.7% in ASV group, without significant differences between the two groups. Mean duration of follow-up was 28.5±22.1 months; 921 patients (97%) had at least one postoperative clinical and ultrasonographic control. Estimated 48-month survival rates were 81% in HePTFE group and 74% in ASV group (P=0.7, log rank 0.1). Primary patency rate at 48 months was significantly better in ASV group (61%) than in HePTFE group (44.5%; P=0.004, log rank 8.1). The rates of secondary patency at 48 months were 57% in HePTFE group and 67.5% in ASV group (P=0.1, log rank 1.9); the corresponding values in terms of limb salvage in patients with critical limb ischemia were 77% and 79.5% (P=0.3, log rank 0.9), respectively. CONCLUSION: Data from this large, retrospective registry confirmed that the indexed heparin-bonded ePTFE graft provides satisfactory early and mid-term results in patients undergoing surgical below-knee revascularization. While autologous saphenous vein maintains its superiority in terms of primary patency, secondary patency and limb salvage rates are comparable.


Subject(s)
Arterial Occlusive Diseases/surgery , Blood Vessel Prosthesis , Femoral Artery/surgery , Heparin/pharmacology , Polytetrafluoroethylene , Popliteal Artery/surgery , Saphenous Vein/transplantation , Aged , Angiography , Anticoagulants/pharmacology , Arterial Occlusive Diseases/diagnosis , Arterial Occlusive Diseases/physiopathology , Coated Materials, Biocompatible , Female , Femoral Artery/physiopathology , Follow-Up Studies , Humans , Italy , Male , Prosthesis Design , Recurrence , Registries , Retrospective Studies , Time Factors , Transplantation, Autologous , Treatment Outcome , Ultrasonography, Doppler, Duplex , Vascular Patency
4.
Ann Ital Chir ; 73(2): 211-7; discussion 217-8, 2002.
Article in Italian | MEDLINE | ID: mdl-12197295

ABSTRACT

Satisfactory palliation of the lesions involving the carinal region is difficult to achieve because the stenting is conducted in an unsuitable anatomy, in highly symptomatic patients. During the period 1987-2000 we performed 785 operative rigid bronchoscopies in 524 patients, 184 of whom received a respiratory stent. The stenting of the carinal region was carried out in 27 patients with the use of the Frietag Dynamic stent. In this group of patients indication for stenting was as follows:--advanced lung cancer (22);--esophageal cancer invading the lower trachea (1);--severe tracheobronchomalacia (2);--postintubation stenosis of the lower trachea (2). No perioperative mortality was observed. All patients experienced symptomatic improvement. Follow-up ranged from 1 to 60 months: all neoplastic patients died for advanced disease without significant respiratory problems with a median survival of 5.6 months; three patients treated for benign diseases are still alive at 2, 31 and 65 months from stent deployment. No major complications were observed: in two patients the stent was removed after few days due to mucous retention; furthermore we observed symptomatic respiratory infections caused by a residual space between the tracheal wall and the prosthesis in other two patients with severe COPD. Dynamic stent is to be considered the stent of choice for palliation of the carinal region because it is effective and well tolerated with a low complications rate. The main limitations of such prosthesis are the shortness of the right bronchial branch and the size, sometimes inadequate.


Subject(s)
Stents , Tracheal Stenosis/therapy , Adult , Aged , Aged, 80 and over , Bronchoscopy , Female , Follow-Up Studies , Humans , Lung Neoplasms/complications , Male , Middle Aged , Palliative Care , Stents/adverse effects , Time Factors , Tracheal Diseases/complications , Tracheal Neoplasms/complications , Tracheal Stenosis/etiology
5.
Minerva Endocrinol ; 26(4): 247-53, 2001 Dec.
Article in Italian | MEDLINE | ID: mdl-11782710

ABSTRACT

Small cell lung cancer (SCLC) is a biologically aggressive tumor with a low long-term survival rate. SCLC is highly responsive to chemotherapy and surgery has a very limited role in its treatment because the disease is usually widely disseminated at the diagnosis. Good results from surgery have been reported in the small subgroup of T1-2 N0 M0 patients. In N1 peripheral SCLC, surgery in combination with other treatments, can obtain fair results. Surgical treatment does not influence the prognosis in SCLC as stage III and IV.


Subject(s)
Carcinoma, Small Cell/surgery , Lung Neoplasms/surgery , Aged , Antineoplastic Agents/therapeutic use , Carcinoma, Small Cell/drug therapy , Combined Modality Therapy , Female , Humans , Lung Neoplasms/drug therapy , Male , Middle Aged , Neoplasm Staging
7.
Cancer Res ; 57(13): 2661-7, 1997 Jul 01.
Article in English | MEDLINE | ID: mdl-9205074

ABSTRACT

Resistance of colorectal cancer cells to chemotherapeutic drugs increases as cells reach confluence. Here we show that the small stress protein HSP27, which has been described to block necrotic and apoptotic cell death, accumulates in confluent human colorectal cancer cell lines HT-29 and Caco2. Cell confluence also induces HSP27 phosphorylation and changes in its intracellular distribution. We also show that overexpression of human HSP27 by transfection of HT-29 cells increased the resistance of cells to doxorubicin or cisplatin and prevented drug-induced apoptosis. Interestingly, nonconfluent HSP27-transfected cells and confluent control cells in which HSP27 is expressed at the same level displayed a similar drug resistance. HSP27-transfected cells did not exhibit an enhanced resistance when they reached confluence, nor was there an increased accumulation of HSP27. We have previously shown that HSP27 expression blocks tumor necrosis factor-induced cell death as a result of decreasing intracellular reactive oxygen species (ROS). Here we show that HSP27 overexpression in HT-29 cells, obtained either by transfection or by growing the cells at high density, correlated with a significant ROS decrease. We conclude that cell confluent-dependent HSP27 accumulation, probably due to its ability to decrease ROS levels, is essential for the establishment of the resistance of colorectal cancer cells when reaching confluence.


Subject(s)
Apoptosis , Colorectal Neoplasms/metabolism , Drug Resistance, Neoplasm , Protein Serine-Threonine Kinases/metabolism , Cell Count , Cisplatin/pharmacology , Colorectal Neoplasms/pathology , Culture Media, Serum-Free/metabolism , Doxorubicin/pharmacology , HT29 Cells , Humans , Immunoblotting , Intracellular Signaling Peptides and Proteins , Phosphorylation , Protein-Tyrosine Kinases , Proto-Oncogene Proteins/metabolism , RNA, Messenger/metabolism , Receptor Protein-Tyrosine Kinases/metabolism , Subcellular Fractions/metabolism , Transfection , Tumor Cells, Cultured
8.
Appl Opt ; 35(7): 1129-34, 1996 Mar 01.
Article in English | MEDLINE | ID: mdl-21085224

ABSTRACT

The propagation of several modes in an optical fiber is not easy to study. The experiment that we propose permits us to measure the difference in time propagation between two successive modes of a multimode fiber. The same laser beam is coupled into the fiber to be tested and into the reference single-mode fiber. The correlation of output electric fields of the modes propagated by each fiber is realized by an interferometric system.

9.
Quad Sclavo Diagn ; 18(4): 440-6, 1982 Dec.
Article in Italian | MEDLINE | ID: mdl-7186646

ABSTRACT

After a brief review of the methods for determination of urea by continuous flow analyzers, a method is described based on the urease splitting of urea followed by NH3 reaction with alfa-ketoglutarate + NADH2 catalysed by GLDH. The method has been applied to continuous flow analyzers and seems to be promising.


Subject(s)
Urea/blood , Glutamate Dehydrogenase , Methods , Urea/analysis , Urease
13.
Rev Stomatol Chir Maxillofac ; 76(3): 241-50, 1975.
Article in French | MEDLINE | ID: mdl-1057231

ABSTRACT

A diffuse papulo-erosive histiocytosis of the oral mucosa occurred during the fourth year of progression of a case of multiple maxillary eosinophilic granuloma whilst the bone lesions were progressing favourably. This mucosal form appeared to have completed its course in approximately one year, i.e. much more quickly than each of the bony lesions.


Subject(s)
Eosinophilic Granuloma/complications , Jaw Diseases/complications , Lymphatic Diseases/complications , Mouth Mucosa , Mouth Neoplasms/complications , Aged , Eosinophilic Granuloma/pathology , Female , Fractures, Spontaneous/etiology , Humans , Jaw Diseases/pathology , Lymphatic Diseases/pathology , Mandibular Fractures/etiology , Mouth Mucosa/pathology , Mouth Neoplasms/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...